Agent successfully gathered a comprehensive overview of Sable Peptides' business model, pricing, and positioning by fetching the homepage, shop, about, and FAQ pages. The site is well-navigable with clear, plain-language content on all key dimensions—though some claims (like incorporation dates and competitive positioning) raised flags the agent could not independently verify, and the site offered no third-party comparisons or customer evidence.

• ›All four content-bearing steps were directly on the domain: homepage [0] supplied company basics and catalog overview; shop [1] enumerated product categories and price examples; about [2] articulated the value proposition and scope boundaries; FAQ [3] clarified delivery, quality, payment, and compliance. The site is well-structured for discovery.
• ›Steps [0], [3] were reached via agent memory (typed URLs), not site navigation links—suggesting the site lacks explicit navigation or links to FAQ and FAQ is discoverable only if you know to type /faq. Only [1] was discovered via a link from [0].
• ›The final response flags an internal inconsistency the agent could not resolve: the site claims operation 'since 2019' but states incorporation in 'September 2026'—a future date. This discrepancy appears in [0] and [2] and the agent noted it, but the site itself offers no explanation.
• ›Pricing section [1] provided concrete examples and the price-match guarantee claim, but the site supplied no data on volume discounts, contract pricing, or how the daily comparison is performed—the agent inferred this absence correctly.
• ›The site explicitly positions itself as 'research use only' and reiterates compliance multiple times ([0], [2], [3]), but provides no customer roster, case studies, or competitive alternatives, forcing the agent to note that the market position is inferred, not documented.